Marije E Otto

10PUBLICATIONS
28CO-AUTHORS
PharmacogenomicsToxicology (incl. clinical toxicology)Large and complex data theoryHydrodynamics and hydraulic engineeringPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 06, 2026
Pharmacokinetics and pharmacodynamics of intravenous and oral (S)-ketamine: Investigating metabolite contribution to subjective effects.

Marije E Otto, Gabriël E Jacobs, Joost C van Mechelen

|May 13, 2025
Safety, Pharmacokinetics, and Pharmacodynamics of a 6-h N,N-Dimethyltryptamine (DMT) Infusion in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial.

Katelijne V van der Heijden, Rob G J A Zuiker, Marije E Otto

|Feb 21, 2025
Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post‑Hoc Analysis.

Marije E Otto, Katelijne V van der Heijden, Jan W Schoones

|Jan 21, 2025
Clinical Pharmacokinetics of N,N-Dimethyltryptamine (DMT): A Systematic Review and Post-hoc Analysis.

K V van der Heijden, M E Otto, J W Schoones

|Jan 15, 2025
Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.

Marije E Otto, Katelijne V van der Heijden, Jan W Schoones

|Dec 06, 2024
TMS and EEG Pharmacodynamic Effects of a Selective Sphingosine-1-Phosphate Subtype 1 Receptor Agonist on Cortical Excitability in Healthy Subjects.

Catherine M K E de Cuba, Annika A de Goede, Erica S Klaassen

Pageof 2

Frequent Collaborators

4 joint publications

Katelijne V van der Heijden

4 joint publications

Michiel J van Esdonk

4 joint publications

Laura G J M Borghans

3 joint publications

Jan W Schoones